Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease.
about
Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury.Therapeutic Strategies for Oxidative Stress-Related Cardiovascular Diseases: Removal of Excess Reactive Oxygen Species in Adult Stem CellsRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsHuman adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep.Different culture conditions modulate the immunological properties of adipose stem cells.MSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplantSuppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2.Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid ArthritisMesenchymal stem cells: are we ready for clinical application in transplantation and tissue regeneration?Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton's jelly and bone marrowEffect of Single and Double Administration of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Following Focal Cerebral Ischemia in Rats.Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.Mesenchymal stem cells in the treatment of pediatric diseases.Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.Advancing stem cell therapy from bench to bedside: lessons from drug therapiesPainting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage.Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear CellsBone marrow-derived mesenchymal stem cells reduce immune reaction in a mouse model of allergic rhinitis.Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy.Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.Pollen-induced antigen presentation by mesenchymal stem cells and T cells from allergic rhinitis.Novel treatment options for ulcerative colitis.Allogeneic cell therapy: a new paradigm in therapeutics.Mesenchymal stem cell-based therapy for radiation-induced lung injury.Multipotent Adult Progenitor Cells Support Lymphatic Regeneration at Multiple Anatomical Levels during Wound Healing and Lymphedema.Effects of human umbilical cord-derived mesenchymal stem cells on hematologic malignancies.The Safety of Non-Expanded Multipotential Stromal Cell Therapies
P2860
Q27305817-BB462405-DF79-481D-8837-3E4167151834Q28077974-7ECD1130-1994-4E2A-A221-1907B20E5F7EQ28079823-F368BA99-2368-4769-88B2-F5A74B2EDF8BQ33746517-16002224-2816-4FF7-AEFF-B728816A9BAAQ34273076-7AC12682-E0E4-497C-B88E-4AA9DDD35C3FQ34278561-4C64253D-43CF-44B0-986A-699520CA051DQ36757169-D02BD638-E0B9-4C48-AC74-1F373BA2BCE3Q36808606-41DFD3F5-6001-434A-8F22-D3C9B3AAE412Q36917428-BB16E0F9-1393-449E-B2BC-774326D100B7Q37150333-9A839270-CB18-448A-88B7-4FA547720308Q37393107-2618927F-F592-46AD-B0AF-EEF9A999C502Q37667107-15B26334-E442-4430-BA8A-2CF718CDE410Q38110707-E242570D-75E0-454E-910C-115DFFB4B4BAQ38127615-8965EA29-C557-4173-85B9-2757B09A789CQ38186634-25E2D019-1A13-4FB3-8812-69E79E30AF4CQ38245564-84CBE6BB-C35A-48F4-8990-399DFA8F2235Q38407079-76F85783-03EA-4FFF-B687-41DC1C8C3FB2Q38730028-6DB876DE-2553-4AFC-B6B2-116C576D2C85Q38936385-575CC5CB-E62F-4ADA-AE3E-1E652EAE836DQ39012031-A9544DEE-395D-4A90-83F1-4F5AEDF6474BQ40400293-4CC8B2A9-249E-4E36-BDA4-E22AC51749CAQ40634775-4FABE361-A852-4F70-8FA3-5D8495B60D53Q41436644-7B388F26-EA23-4F83-96D0-BFFB06E0D6D8Q41638176-BDEA780A-8F72-45A7-ACB9-74AAB12B7ABEQ41691954-7EE08406-28E2-438B-95FE-743FC1CE95BCQ41949151-570793E5-F27D-466D-A9AC-94F36D26530CQ42545530-E672FDE7-453A-4D34-9E0D-903884FD5A99Q49547836-DA384F3D-D0FE-4E15-BD75-B0DC24DF1D45Q52370114-DCF6070F-E895-49FA-8B0B-1423B3733532Q55202662-45BAFDDC-687C-4CE9-8B04-F5C90C1C62B5Q56837269-50FD9822-345D-4E40-B41C-C3C6A7843810
P2860
Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Application of MultiStem(®) Al ...... for Graft Versus Host Disease.
@en
type
label
Application of MultiStem(®) Al ...... for Graft Versus Host Disease.
@en
prefLabel
Application of MultiStem(®) Al ...... for Graft Versus Host Disease.
@en
P2093
P2860
P356
P1476
Application of MultiStem(®) Al ...... for Graft Versus Host Disease.
@en
P2093
Jef Pinxteren
Robert Deans
Wouter Van't Hof
P2860
P356
10.3389/FIMMU.2012.00345
P577
2012-11-27T00:00:00Z